| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,827 |
2,156 |
$274.64 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
408 |
405 |
$268.09 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
392 |
390 |
$167.79 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,697 |
1,513 |
$125.44 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
712 |
547 |
$60.88 |
| 86592 |
|
155 |
155 |
$3.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
366 |
336 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
557 |
554 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
258 |
255 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,392 |
1,367 |
$0.00 |
| 99443 |
|
173 |
163 |
$0.00 |
| 85027 |
|
95 |
94 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,142 |
2,885 |
$0.00 |
| 90686 |
|
194 |
193 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
81 |
80 |
$0.00 |
| 87088 |
|
25 |
25 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,696 |
1,691 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,635 |
1,597 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
45 |
38 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
135 |
135 |
$0.00 |
| 99441 |
|
227 |
224 |
$0.00 |
| 86780 |
|
87 |
87 |
$0.00 |
| 4450F |
|
66 |
65 |
$0.00 |
| 1220F |
|
74 |
71 |
$0.00 |
| 92551 |
|
51 |
51 |
$0.00 |
| 87340 |
|
13 |
13 |
$0.00 |
| 82043 |
|
30 |
30 |
$0.00 |
| 81001 |
|
40 |
40 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
38 |
25 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
27 |
27 |
$0.00 |
| 99442 |
|
1,144 |
1,072 |
$0.00 |
| 86703 |
|
513 |
511 |
$0.00 |
| 80061 |
Lipid panel |
1,611 |
1,604 |
$0.00 |
| 99173 |
|
120 |
120 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
117 |
117 |
$0.00 |
| 80076 |
|
66 |
66 |
$0.00 |
| 82540 |
|
30 |
30 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
115 |
68 |
$0.00 |
| 84439 |
|
12 |
12 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
70 |
42 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27 |
27 |
$0.00 |
| 84481 |
|
12 |
12 |
$0.00 |
| 1033F |
|
53 |
51 |
$0.00 |